Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation

Lightning Session 1

Monday, August 26, 2024
5:15 PM – 6:45 PM CEST
Location:Room III

Presentations:

  • 5:15 PM – 5:20 PM CEST
    Risk of serious infections in psoriasis/psoriatic arthritis biological drug users: a large-scale, propensity score matched cohort study using the Italian VALORE Project distributed database

    Presenting Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona

    Co-Author: Massimo Carollo – University of Verona, Verona

    Co-Author: Federica Soardo – University of Verona, Verona

    Co-Author: Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Clèment Mathieu – University of Verona, Verona

    Co-Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy

    Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy

    Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia

    Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy

    Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy

    Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy

    Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy

    Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service

    Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy

    Co-Author: Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy

    Co-Author: Stefania Spila Alegiani – Italian National Institute of Health

    Co-Author: Marco Massari – Italian National Institute of Health

    Co-Author: Claudio Guarneri – claudio.guarneri@unime.it

    Co-Author: Paolo Gisondi – paolo.gisondi@univr.it

    Co-Author: Andrea Fontana – Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

    Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona

  • 5:20 PM – 5:25 PM CEST
    Comparative safety of biologic and targeted-synthetic DMARDs in patients with rheumatoid arthritis: a multi-database real-world cohort study

    Presenting Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

    Co-Author: Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

    Co-Author: Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

  • 5:25 PM – 5:30 PM CEST
    The effectiveness of adalimumab biosimilars and originator for the treatment of Psoriasis: A target trial emulation study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

    Presenting Author: Duc Binh Phan, MSc – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.

    Co-Author: Anthony Bewley – Barts Health NHS Trust and Queen Mary University of London Medical School, London, United Kingdom.

    Co-Author: Philip Laws – Department of Dermatology, University of Leeds, Leeds, United Kingdom.

    Co-Author: Teena Mackenzie – Royal Berkshire NHS Foundation Trust, Reading, United Kingdom.

    Co-Author: Catherine Smith – St Johns Institute of Dermatology, Guys & St Thomas NHS Foundation Trust, Kings College London, London, United Kingdom.

    Co-Author: Christopher Griffiths – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, Department of Dermatology, King’s College Hospital, King’s College London, London, United Kingdom.

    Co-Author: Mark Lunt – Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, United Kingdom

    Co-Author: Richard B Warren – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.

    Co-Author: Zenas Zee Ngai Yiu – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.

  • 5:30 PM – 5:35 PM CEST
    Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the Italian multi-regional VALORE distributed database network

    Presenting Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona

    Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Massimo Carollo – University of Verona, Verona

    Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy

    Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy

    Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia

    Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy

    Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy

    Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy

    Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy

    Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service

    Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Claudio Guarneri – claudio.guarneri@unime.it

    Co-Author: Paolo Gisondi – paolo.gisondi@univr.it

    Co-Author: Stefania Spila Alegiani – Italian National Institute of Health

    Co-Author: Marco Massari – Italian National Institute of Health

    Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona

  • 5:45 PM – 5:50 PM CEST
    Comparison of Treatment and Outcomes for Inflammatory Bowel Disease Unclassified versus Ulcerative Colitis and Crohn’s Disease

    Co-Author: Nuvall Cherian, MD – University of Pennsylvania

    Presenting Author: James D. Lewis, MD, MSCE (he/him/his) – University of Pennsylvania

  • 5:50 PM – 5:55 PM CEST
    Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System

    Presenting Author: Hugo Jourdain, PhD (he/him/his) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

    Co-Author: Léa Hoisnard – EpiDerme

    Co-Author: Emilie Sbidian – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France

    Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France

  • 5:55 PM – 6:00 PM CEST
    Pattern of use of biological drugs in pediatric patients with immune-mediated inflammatory diseases through the Italian VALORE distributed database network

    Presenting Author: Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Federica Soardo – University of Verona, Verona

    Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona

    Co-Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Clèment Mathieu – University of Verona, Verona

    Co-Author: Massimo Carollo – University of Verona, Verona

    Co-Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy

    Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy

    Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy

    Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia

    Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy

    Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy

    Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy

    Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy

    Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service

    Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy

    Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy

    Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy

    Co-Author: Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy

    Co-Author: Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy

    Co-Author: Marco Tuccori, PharmD, PhD – Unit of Adverse Drug Reactions Monitoring. University Hospital of Pisa; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

    Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy

    Co-Author: Giorgio Costa – APSS Trento

    Co-Author: Silvana Anna Maria Urru – APSS Trento

    Co-Author: Annalisa Campomori – APSS Trento

    Co-Author: Stefania Spila Alegiani – Italian National Institute of Health

    Co-Author: Marco Massari – Italian National Institute of Health

    Co-Author: Alessandra Allotta – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy

    Co-Author: Sebastiano Addario Pollina – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy

    Co-Author: Roberto Da Cas – Italian National Institute of Health

    Co-Author: Giampaolo Bucaneve – Umbria Regional Centre of Pharmacovigilance, Perugia, Italy

    Co-Author: Antea Maria Pia Mangano – Agenzia regionale sanitaria della regione Marche, Ancona, Italy

    Co-Author: Francesco Balducci – Agenzia regionale sanitaria della regione Marche, Ancona, Italy

    Co-Author: Carla Sorrentino – Ufficio Monitoraggio Spesa Farmaci e Dispositivi Medici, Regione Abruzzo, Pescara, Italy

    Co-Author: Ilenia Senesi – Abruzzo Regional Centre of Pharmacovigilance, Perugia, Italy

    Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona

  • 6:00 PM – 6:05 PM CEST
    Estimating the Prevalence of Immunoglobulin A Nephropathy (IgAN) in the European Union: A Weighted Average Estimation Approach Utilizing Diagnostic Procedure Frequency in a Rare Disease Setting

    Presenting Author: Jocelyn Buisker, MSc – Novartis Pharma AG, Basel, Switzerland

    Co-Author: Sigrid Behr, PhD – Novartis Pharma AG

  • 6:15 PM – 6:20 PM CEST
    DARWIN EU® - Age-specific burden of RSV-related disease in Europe

    Co-Author: Johnmary T. Arinze, MD, PhD – Department of Medical Informatics, Erasmus Medical Center

    Co-Author: Miguel Mayer, MD, PhD, MPH, MSc – UPF

    Co-Author: Guillaume Verdy – Centre Hospitalier Universitaire Bordeaux, France

    Co-Author: Maarten van Kessel – Department of Medical Informatics, Erasmus Medical Center

    Co-Author: Juan-Manuel Ramírez-Anguita – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

    Co-Author: Angela Leis, PhD PsyM – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

    Co-Author: Romain Griffier, MD – Centre Hospitalier Universitaire Bordeaux, France

    Co-Author: Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia

    Co-Author: Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia

    Co-Author: Antonella Delmestri, PhD (she/her/hers) – University of Oxford

    Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)

    Co-Author: James Brash, PhD – IQVIA

    Co-Author: Dina Vojinovic, MD, PhD – IQVIA

    Co-Author: Hanne Ballegooijen – IQVIA

    Co-Author: Sarah Seager, MS – IQVIA

    Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol

    Presenting Author: Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC

  • 6:20 PM – 6:25 PM CEST
    Disease Pattern, Serotype Distribution and Healthcare Resources Utilisation of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong – A Population-based Study

    Presenting Author: Jack Chi Him Lau, MPH (he/him/his) – The University of Hong Kong

    Co-Author: Keith Wai-ki Cheung – The University of Hong Kong

    Co-Author: Kim Shijian Lao, PhD – Global Medical and Scientific Affairs, MSD, Hong Kong, China

    Co-Author: Celine SL Chui, PhD – School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong

  • 6:25 PM – 6:30 PM CEST
    Risk of hospitalized pneumonia among patients receiving opioids: Self-Controlled Case Series study

    Presenting Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan

    Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan

  • 6:30 PM – 6:35 PM CEST
    Evaluating the Differential Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease with Biological and Targeted Synthetic DMARDs: A Nationwide Cohort Study in Taiwan

    Presenting Author: Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University

    Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan